Brooklyn Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Brooklyn Investment Group's BMY Position: Q1 2026 in Review
Brooklyn Investment Group increased its Bristol-Myers Squibb (BMY) stake by 61% in Q1 2026, buying an estimated $1.1M and bringing the position to 49,904 shares worth $3.03M. The position accounts for 0.09% of the portfolio, ranked #174.
Brooklyn Investment Group first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Brooklyn Investment Group held 49,904 shares of Bristol-Myers Squibb worth $3.03M as of Q1 2026.
- Brooklyn Investment Group bought 18,954 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.1M.
- Bristol-Myers Squibb made up 0.09% of Brooklyn Investment Group's portfolio in Q1 2026, its #174 holding.
- Brooklyn Investment Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.